Table 3.

The association between rs1800504 and the risk of CHD in T2DM patients.

Model	Genotype	Number of patients (%)		OR (95%CI)	p-value
		CHD (n = 248)	Non-CHD (n = 680)
Additive model*	TT	26 (16.3)	134 (19.7)	Ref.	/
	CT	146 (30.6)	327 (48.1)	2.35 (1.40–3.95)	0.001
	CC	76 (25.9)	215 (31.6)	2.07 (1.18–3.61)	0.011
Dominant model	CC	76 (25.9)	215 (31.6)	Ref.	/
	CT+TT	172 (69.4)	461 (67.8)	1.06 (7.38–1.53)	0.74
Recessive model*	TT	26 (16.3)	134 (19.7)	Ref.	/
	CC+CT	222 (89.5)	542 (79.7)	2.24 (1.36–3.70)	0.002

CHD, coronary heart disease. Ref., reference.

^*p < 0.05, indicates a significant statistical difference. The bold values mean p value is less than 0.05.